What to Report
Oklahoma Administrative Code (OAC) 310:515 specifies which diseases and conditions are reportable and the timeframe and methods for reporting.
Reportable Disease Rules – OAC 310:515
The Disease Reporting Manual further defines the specifics for clinical and laboratory reporting requirements for diseases and conditions. In addition to reporting requirements, the manual contains guidance in determining if an event should be reported, and specifies which specimens and isolates are required to be forwarded to the OSDH Public Health Laboratory.
Oklahoma Disease Reporting Manual
Reportable diseases and conditions poster(s):
Reportable Diseases/Conditions Poster for Healthcare Providers
Reportable Pathogens Poster for Laboratories
The following diseases are to be reported to the OSDH by PHIDDO or telephone (405-271-4060) immediately upon suspicion, diagnosis, or positive test:
Anthrax | Measles (Rubeola) | Poliomyelitis |
Bioterrorism-suspected disease | Meningococcal invasive disease |
Rabies |
Botulism | Novel coronavirus | Smallpox |
Diphtheria | Novel influenza A | Typhoid fever |
Free-living amebae infections causing primary amebic meningoencephalitis | Outbreaks of apparent infectious disease | Viral hemorrhagic fever |
Hepatitis B during pregnancy (HBsAg+) |
Plague |
The following diseases are to be reported to the OSDH by PHIDDO or telephone within one business day:
Acid Fast Bacillus (AFB) positive smear (only if no additional testing is performed or subsequent testing is indicative of Mycobacterium tuberculosis Complex) | Lyme disease |
AIDS (Acquired Immunodeficiency Syndrome) | Malaria |
Anaplasmosis | Mumps |
Brucellosis | Pertussis |
California serogroup virus infection | Powassan virus infection |
Campylobacteriosis | Psittacosis |
Chikungunya virus infection | Q Fever |
Congenital rubella syndrome | Rubella |
Cryptosporidiosis | Salmonellosis |
Dengue fever | Shigellosis |
Eastern equine encephalitis virus infection | Spotted Fever Rickettsiosis (Rickettsia spp.) hospitalization or death |
E. coli O157, O157:H7 or a Shiga toxin producing E. coli (STEC) | St. Louis encephalitis virus infection |
Ehrlichiosis | Streptococcal disease, invasive, Group A (GAS) |
Haemophilus influenza invasive disease | Streptococcus pneumoniae invasive disease, children <5 yrs. |
Hantavirus infection, without pulmonary syndrome | Syphilis (Nontreponemal and treponemal tests are reportable. If any syphilis test is positive, then all syphilis test results on the panel must be reported. For infants |
Hantavirus pulmonary syndrome | Tetanus |
Hemolytic uremic syndrome, postdiarrheal | Trichinellosis |
Hepatitis A (Anti-HAV-IgM+) | Tuberculosis |
Hepatitis B (HBsAg+, anti-HBc IgM+, HBeAg+, and/or HBV DNA+) 1 | Tularemia |
Hepatitis C virus (having jaundice or ALT ≥ 200 with laboratory confirmation) 1 | Unusual disease or syndrome |
Human Immunodeficiency Virus (HIV) infection | Vibriosis including cholera |
Influenza associated hospitalization or death | West Nile virus infection |
Legionellosis | Western Equine encephalitis virus infection |
Leptospirosis | Yellow fever |
Listeriosis | Zika virus infection |
1 with entire Hepatitis panel results
The following diseases are to be reported to the OSDH by PHIDDO or telephone within one month:
CD4 Cell Count with cell count % (by laboratories only) |
Creutzfeldt-Jakob disease | HIV viral load (by laboratories only) |
Chlamydial infections (C. trachomatis) |
Gonorrhea |
Isolates of the following organisms must be sent to the OSDH Public Health Laboratory: P.O. Box 24106 OKC, OK 73124:
Bacillus anthracis | Mycobacterium tuberculosis |
Brucella spp. | N. meningitidis (sterile site isolates only) |
Carbapenem-resistant Enterobacteriaceae | Plasmodium spp. |
E. coli O157, O157:H7 or a Shiga toxin producing E. coli | Salmonella spp. |
Francisella tularensis | Vibrionaceae family (Vibrio spp., Grimontia spp., Photobacterium spp., and other genera in the family) |
H. influenzae (sterile site isolates only) | Yersinia spp. |
Listeria spp. (sterile site isolates only) |
Occupational or Environmental diseases:
The following laboratory results for adults and children must be reported to the OSDH Oklahoma Childhood Lead Poisoning Prevention Program.
Laboratories and health care providers doing in-office testing must report blood lead level results equal to or greater than 5 µg/dL within one (1) week and results less than 5 µg/dL within one (1) month.
Laboratories and all health care providers must report blood lead level results of 20 µg/dL or greater within twenty-four (24) hours.